⌕
Guardant Health · GH · Nasdaq
Tenet 48 · Mixed
Compare
$143.28−0.52%At closeTenet 48 · Mixed
$143.28−0.75 (−0.52%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Guardant Health (GH) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Business engineGrowing fast: revenue compounds ~27.3%/yr (FY21→FY25), net margin −42.4%. Worth your attention in FY25: Share count (+23.7%) and Returns vs FCF (n/m). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲32.9%
982.0
FY21→FY25CAGR +27.3%/yr
Net income ($M)▲4.6%
−416.3
FY21→FY25CAGR —
Free cash flow ($M)▲15.2%
−233.1
FY21→FY25CAGR —
Diluted EPS▲6.7%
−3.32
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+23.7%

101.3mn → 125.4mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$48.3M

+37.7% YoY in FY25 · 4.9% of revenue.

Returns vs FCF
n/m

$62.7M returned vs $−233.1M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)982.0Revenue−349.0COGS633.0Gross profit−364.2R&D−211.4SG&A−437.2Op income21.0Tax & other−416.3Net income

-42¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
705335180%sector median net margin ~3%FY21FY25

Net margin -42.4% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
1,278,884.0982,021.0739,016.0563,948.0449,538.0373,653.0▲32.9%+27.3%
Cost of revenue
445,182.0349,007.0289,799.0227,052.08,126.012,516.0▲20.4%+129.8%
Gross profit
833,702.0633,014.0449,217.0336,896.0—A—A▲40.9%+37.1%
Research & development
386,673.0364,191.0347,753.0367,194.0373,807.0263,221.0▲4.7%+8.5%
Selling, general & admin
271,381.0211,410.0180,123.0239,200.0163,956.0206,640.0▲17.4%+0.6%
Total operating expenses
1,337,740.01,070,262.0892,811.0901,621.0985,790.0772,138.0▲19.9%+8.5%
Operating incomefeeds ROC rank
−504,038.0−437,248.0−443,594.0−564,725.0−544,378.0−411,001.0▲1.4%—
Other income, net
18,138.019,708.08,505.085,961.0−109,071.026,531.0——
Pretax income
−485,900.0−417,540.0−435,089.0−478,764.0−653,449.0−384,470.0▲4.0%—
Income tax
−827.0−1,263.01,284.0685.01,139.0300.0——
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−485,073.0−416,277.0−436,373.0−479,449.0−654,588.0−384,770.0▲4.6%—
Per share
Diluted EPSbuyback-sensitive
−3.69−3.32−3.56−4.28−6.41−4.00▲6.7%—
Diluted shares (mn)
134.42125.37122.75111.99102.18101.31▲2.1%+5.5%
Margins
Gross margin49th pct in Healthcare
65.2%64.5%60.8%59.7%—A—A▲3.7pp+4.7pp
Operating margin
−39.4%−44.5%−60.0%−100.1%−121.1%−110.0%▲15.5pp+65.5pp
Net margin16th pct in Healthcare
−37.9%−42.4%−59.0%−85.0%−145.6%−103.0%▲16.7pp+60.6pp
† TTM = trailing four quarters through 2026-09-30.A Withheld: this year's gross margin is not on the same cost basis as the earlier years.
FY16 – FY20 · 5 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-19 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Guardant Health's revenue last fiscal year?

Guardant Health reported revenue of $982.0M in fiscal 2025, up 32.9% from fiscal 2024.

What was Guardant Health's net income?

Guardant Health reported net income of −$416.3M in fiscal 2025, a net margin of −42.4%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.